Please assess the completion status of the following clinical trial:

Trial Title: Withdrawal of Steroids, Cyclosporine A Dose Reduction and Switch to Mycophenolatmofetile After Heart Transplantation

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Current immunosuppressive regimen: Cyclosporine A and corticosteroids for at least six month~* Heart transplantation above 3 years dated back~* Serum creatinine \< 3,5 mg/dl (310 µmol/l) and BUN \< 150 mg/dl~* Cyclosporine A blood level between 50 and 250 ng/ml during the last 12 month~Exclusion Criteria:~* Carcinoma within the last 3 years~* Acute rejection episodes during the last 6 month~* Infection requiring therapeutic intervention~* Hepatitis B, Hepatitis C or HIV infection~* WBC \< 3000/µl, haemoglobin \< 9g/dl, platelets \< 70.000/µl~* Florid gastrointestinal ulcer~* Haemodialysis within the last 4 weeks before study entry~* Pregnancy / lactation~* Administration of other immunosuppressive agents than prescribed~* Mycophenolatmofetile incompatibility

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): prednisolon withdrawal: reduction of maintenance dosage, 0,5 mg of the daily dose every week till withdrawal; Mycophenolatmofetile administration: start doses 250 mg, increase of the daily dose about 250 mg every week till reaching 2 g/daily; Cyclosporin A reduction: 8 weeks after starting prednisolon withdrawal and Mycophenolatmofetile administration reduction of Cyclosporin A trough level till a range from 50 to 90 mg/ml

Based on this trial design, predict the completion outcome and termination type (if applicable).